无症状人群全身MRI的应用前景与隐患
本AJR专家小组叙述性综述探讨全身MRI在无症状人群中的现有及新兴应用。文章指出全身MRI主要用于多癌筛查,但缺乏临床获益证据及指南支持,且存在过度诊断、成本及伦理问题。未来需前瞻性试验验证其临床效益与成本效果。
要点
- 全身MRI用于无症状人群多癌筛查,但缺乏临床获益证据及指南支持。
- 发现不确定病灶可能带来过度诊断、过度治疗及额外检查负担。
- 阅片时应警惕偶然发现的临床相关性,避免引发不必要的后续干预。
核心结论
- 全身MRI在无症状个体中日益增多,但现有证据不足以支持其临床获益,缺乏指南认可。
- 未来需通过前瞻性试验评估临床效益与成本效果,识别潜在中危人群进行定向筛查。
研究设计与样本
- 研究类型为专家小组叙述性综述,非系统综述或荟萃分析。
- 由AJR专家小组撰写,探讨当前及新兴的全身MRI在无症状人群中的应用。
- 参照现有可获得的证据,讨论全身MRI的前景与陷阱。
关键影像表现/征象
- 全身MRI可检测出多癌种,研究迄今主要关注检出频率。
- 非肿瘤方面应用包括颅内动脉瘤检测、定量体成分分析及肌肉骨骼评估。
诊断标准与关键数值
- 文章未报告敏感度、特异度、AUC、阈值或分级标准的具体数值。
临床应用与阅片要点
- 阅片时注意偶然发现的临床意义不确定,可能引发后续一系列检查。
- 报告应客观描述所见,避免过度解读惰性病变,减少过度诊断风险。
- 需建立标准化采集与报告框架,支持全身MRI的规范化实施。
- 人工智能工作流程正在探索中,有望辅助全身MRI的判读与实施。
- 应关注商业推广对患者知情同意及心理社会层面的影响。
局限性
- 缺乏支持全身MRI临床影响的充分证据,缺少指南对无症状人群筛查的认可。
- 身体MRI伴随潜在危害,包括对不确定病灶的进一步检查、惰性疾病的过度诊断与过度治疗。
- 直接及下游成本显著,包括后续检查与处理带来的经济负担。
- 存在伦理困境,涉及不受监管的商业广告、知情同意及心理社会后果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This AJR Expert Panel Narrative Review examines current and emerging applications of whole-body MRI (WB-MRI) in asymptomatic individuals, addressing the examination's promise and pitfalls in context of available evidence. WB-MRI is being used in asymptomatic individuals primarily for multicancer detection, with research to date focusing on detection frequencies. Nononcologic applications include intracranial aneurysm detection, quantitative body composition analysis, and musculoskeletal assessment. Standardized acquisition and reporting frameworks and artificial intelligence workflows are being pursued to support WB-MRI implementation. WB-MRI is increasingly performed in the general population (i.e., individuals without cancer risk factors) as preventive healthcare, partly driven by a growing commercial market, despite limited evidence supporting clinical impact and lack of guidelines endorsing the practice. Moreover, WB-MRI carries potential harms from workup of indeterminate findings, overdiagnosis and overtreatment of indolent disease, and substantial direct and downstream costs. Additional ethical dilemmas relate to unregulated commercial advertising, appropriate informed consent, and psychosocial consequences. The article finally considers strategies to move the field forward, emphasizing the need for prospective trials assessing clinical benefit and cost-effectiveness, identification of potential intermediate-risk populations for targeted screening, and development of quality standards and communication models to ensure that WB-MRI evolves into a beneficial rather than harmful medical tool.
引用
- Petralia, Akin, Brookmeyer, et al. Whole-Body MRI in Asymptomatic Individuals: Promise and Perils-AJR Expert Panel Review. AJR Am J Roentgenol. 2026. PMID: 42776581. doi:10.2214/AJR.26.35420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。